Skip to main content
. 2016 Jul 25;2016:3762561. doi: 10.1155/2016/3762561

Table 2.

OGG1-BER induced expression of genes associated to AHR.

Symbol Name GenBank/RefSeq ID SC (fold) MC (fold)
Cxcl2 Chemokine (C-X-C motif) ligand 2 NM_009140 192.95 48.55
Bdkrb2 Bradykinin receptor, beta 2 NM_009747 −1.35 45.16
Il10 Interleukin 10 NM_010548 5.84 33.51
Tlr9 Toll-like receptor 9 NM_031178 −1.54 25.97
Arg1 Arginase, liver NM_007482 −5.00 17.71
Cxcl1 Chemokine (C-X-C motif) ligand 1 NM_008176 54.45 15.94
Esr1 Estrogen receptor 1 (alpha) NM_007956 −5.19 15.56
Alb Albumin NM_009654 −1.74 15.28
Chrm3 Cholinergic receptor, muscarinic 3, cardiac NM_033269 1.66 9.99
Flt1 Fms-like tyrosine kinase 1 NM_010228 −1.13 9.06
Chrm2 Cholinergic receptor, muscarinic 2, cardiac NM_203491 −1.79 8.73
Vip Vasoactive intestinal polypeptide NM_011702 −2.10 7.26
Tnf Tumor necrosis factor NM_013693 16.65 7.13
Col4a3 Collagen, type IV, alpha 3 NM_007734 1.15 6.74
Tac1 Tachykinin 1 NM_009311 −4.28 6.70
Mylk3 Myosin light chain kinase 3 NM_175441 −4.08 6.35
Ppp1r12a Protein phosphatase 1, regulatory (inhib) subunit 12A NM_027892 −1.08 6.06
Ctla4 Cytotoxic T-lymphocyte-associated protein 4 NM_009843 7.08 5.82
Madcam1 Mucosal vascular addressin cell adhesion molecule 1 NM_013591 −1.63 5.66
Il1a Interleukin 1 alpha NM_010554 4.17 5.55
Agmat Agmatine ureohydrolase (agmatinase) NM_001081408 −4.28 5.03
Il1Rn Interleukin 1 receptor antagonist NM_031167 1.92 4.10
Il2Rb Interleukin 2 receptor, beta chain NM_008368 1.31 4.04
Il9R Interleukin 9 receptor NM_008374 1.08 3.96
Edn1 Endothelin 1 NM_010104 3.10 3.81
Prg2 Proteoglycan 2, bone marrow NM_008920 2.21 3.72
Mme Membrane metallo-endopeptidase NM_008604 −1.07 3.66
Ctsg Cathepsin G NM_007800 −1.14 3.35
Itk IL2 inducible T cell kinase NM_010583 1.38 3.34
Pik3r1 PI3Ka, regulatory subunit, polypeptide 1 (p85 alpha) NM_001024955 −1.18 3.24
Mpo Myeloperoxidase NM_010824 1.36 3.24
Ngfr Nerve growth factor receptor NM_033217 −1.88 3.20
Slc7a1 Solute carrier family 7, member 1 NM_007513 −1.28 3.19
Pde4d Phosphodiesterase 4D, cAMP specific NM_011056 1.08 3.18
Pde4b Phosphodiesterase 4B, cAMP specific NM_019840 1.39 3.17
Egfr Epidermal growth factor receptor NM_007912 −1.16 3.05
Abl1 C-abl oncogene 1, non-receptor tyrosine kinase NM_001112703 1.11 3.01
Etv6 Ets variant 6 NM_007961 −1.05 2.98
Tacr2 Tachykinin receptor 2 NM_009314 −1.07 2.93
Ccl11 Chemokine (C-C motif) ligand 11 NM_011330 −1.71 2.93
Ttf2 Transcription termination factor, RNA polymerase II NM_001013026 1.06 2.92
Il6 Interleukin 6 NM_031168 10.44 2.75
Pde3b Phosphodiesterase 3B, cGMP-inhibited NM_011055 −1.79 2.68
Pcdh1 Protocadherin 1 NM_029357 −1.12 2.66
Jun Jun proto-oncogene NM_010591 1.38 2.55
Nqo1 NAD(P)Hb dehydrogenase, quinone 1 NM_008706 −2.58 2.54
Il1b Interleukin 1 beta NM_008361 4.15 2.52
Cck Cholecystokinin NM_031161 −1.43 2.51
F2rl1 Coagulation factor II (thrombin) receptor-like 1 NM_007974 1.09 2.51
Mbp Myelin basic protein NM_010777 −1.40 2.48
Itga4 Integrin alpha 4 NM_010576 1.26 2.46
F2r Coagulation factor II (thrombin) receptor NM_010169 1.46 2.39
Selp Selectin, platelet NM_011347 −1.31 2.39
Il2ra Interleukin 2 receptor, alpha chain NM_008367 1.06 2.34
Agtr1a Angiotensin II receptor, type 1a NM_177322 1.72 2.33
Fgfr1 Fibroblast growth factor receptor 1 NM_010206 1.02 2.32
Mylk Myosin, light polypeptide kinase NM_139300 1.24 2.30
Klf15 Kruppel-like factor 15 NM_023184 1.41 2.30
Ltb4r2 Leukotriene B4 receptor 2 NM_020490 −7.37 2.15
Hrh1 Histamine receptor H1 NM_008285 −2.85 2.15
Il5 Interleukin 5 NM_010558 −1.87 2.14
Icam1 Intercellular adhesion molecule 1 NM_010493 1.30 2.12
Irak3 Interleukin-1 receptor-associated kinase 3 NM_028679 −1.19 2.12
Cftr Cystic fibrosis transmembrane conductance regulator NM_021050 1.09 2.11
Elane Elastase, neutrophil expressed NM_015779 −1.43 2.09
Hspd1 Heat shock protein 1 (chaperonin) NM_010477 −2.07 2.06

SC, single 8-oxoG challenge; MC, multiple 8-oxoG challenge; PI3Ka, phosphatidylinositol 3-kinase; NAD(P)Hb, dihydronicotinamide-adenine dinucleotide phosphate. The table shows the top ranked genes (MC, 60 min) by expression level (≥2-fold).